← FDA Drug Approvals (Drugs@FDA)

RADICAVA

NDA · New Drug Application · Sponsor: SHIONOGI · Approved 2017-05-05

Drug application

FDA Application #

NDA209176

Application type

New Drug Application

Brand name

RADICAVA

Generic name

Edaravone

Active ingredients

EDARAVONE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

SHIONOGI

First approval

2017-05-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown